Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M414194200 on March 15, 2005

J. Biol. Chem., Vol. 280, Issue 20, 20120-20125, May 20, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/20/20120    most recent
M414194200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Binks, M. J.
Right arrow Articles by Sriprakash, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binks, M. J.
Right arrow Articles by Sriprakash, K. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Attribution of the Various Inhibitory Actions of the Streptococcal Inhibitor of Complement (SIC) to Regions within the Molecule*

Michael J. Binks{ddagger}, Barbara A. Fernie-King§, David J. Seilly§, Peter J. Lachmann§, and Kadaba S. Sriprakash{ddagger}

From the {ddagger}Queensland Institute of Medical Research, Brisbane, Queensland 4006, Australia and the §Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, United Kingdom

Some strains of Streptococcus pyogenes secrete a virulence factor called the streptococcal inhibitor of complement (SIC) function. SIC is a polyfunctional protein that interacts with a number of host proteins and peptides, especially with those that are involved in host defense systems. In addition to inhibiting the complement-mediated lysis of cells, SIC inhibits lysozyme, secretory leukocyte proteinase inhibitor, and {beta}-defensins. SIC also binds to proteins associated with the cytoskeleton and thereby may cause cytoskeletal derangement. The SIC molecule has three distinct structural domains constituting the N-proximal short repeat region (SRR), the central long repeat region (LRR), and the C-proximal proline-rich region (PRR). To map various functions to the structural domains, we have analyzed recombinant subclones expressing various parts of SIC and elastase-generated discrete fragments of SIC for binding to various ligands and for determining their biological properties. The results demonstrate the following. (a) SRR alone was sufficient to confer inhibition of complement function. (b) Anti-defensin and anti-lysozyme activities were mapped to the SRR plus LRR. (c) The LRR plus PRR harbored ezrin binding activity.


Received for publication, December 17, 2004 , and in revised form, February 23, 2005.

* This work was supported by generous grants from the British Heart Foundation (to P. J. L.) and the National Health and Medical Research Council, Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Queensland Inst. of Medical Research, 300 Herston Rd., Brisbane, Queensland 4006, Australia. Tel.: 61-7-33620407; Fax: 61-7-38453507; E-mail: sriS{at}qimr.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CVIHome page
V. A. F. Boon, J. L. Munro, G. W. Kan, J. Burnell, and R. Speare
Seroreactivity against Streptococcal DRS (Distantly Related to SIC) Protein Is a Predictor for End-Stage Renal Failure
Clin. Vaccine Immunol., November 1, 2008; 15(11): 1699 - 1704.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Hebert, P. Courtin, R. Torelli, M. Sanguinetti, M.-P. Chapot-Chartier, Y. Auffray, and A. Benachour
Enterococcus faecalis Constitutes an Unusual Bacterial Model in Lysozyme Resistance
Infect. Immun., November 1, 2007; 75(11): 5390 - 5398.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
V. Sagar, R. Kumar, N. K. Ganguly, T. Menon, and A. Chakraborti
DRS Is Far Less Divergent than Streptococcal Inhibitor of Complement of Group A Streptococcus
J. Bacteriol., April 1, 2007; 189(7): 2933 - 2935.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
L. A. Kwinn, A. Khosravi, R. K. Aziz, A. M. Timmer, K. S. Doran, M. Kotb, and V. Nizet
Genetic Characterization and Virulence Role of the RALP3/LSA Locus Upstream of the Streptolysin S Operon in Invasive M1T1 Group A Streptococcus
J. Bacteriol., February 15, 2007; 189(4): 1322 - 1329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement